AIM ImmunoTech (AIM) said Tuesday it received a noncompliance notice from NYSE American for failing to meet continued listing requirements.
The company said it was notified about noncompliance with the minimum required stockholders' equity for a company that has reported losses from continuing operations and net losses in its five most recent fiscal years.
AIM said the notice has no immediate impact on its listing status and does not affect its business operations or its reporting requirements with the US Securities and Exchange Commission.
The company said it has until Jan. 10 to submit a plan to regain compliance.
Shares of the company were down nearly 5% in recent after-hours activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。